International Nonproprietary N |
Recommended INN: List 83 | WHO Drug Information,2020,34,1 | 查看 |
Consultation Documents |
Revision of WHO GMP for Sterile Pharmaceutical Products – A Joint EU, PIC/S, WHO Project | WHO Drug Information,2020,34,1 | 查看 |
Consultation Documents |
Policy Evaluating and Publicly designating Regulatory Authorities as WHO Listed Authorities | WHO Drug Information,2020,34,1 | 查看 |
International Nonproprietary N |
Proposed INN: List 122 | WHO Drug Information,2019,33,4 | 查看 |
Consultation Documents |
ATC/DDD Classification (Final) | WHO Drug Information,2019,33,4 | 查看 |
Consultation Documents |
ATC/DDD Classification (Temporary) | WHO Drug Information,2019,33,4 | 查看 |
Consultation Documents |
Guideline on data integrity | WHO Drug Information,2019,33,4 | 查看 |
Consultation Documents |
Proposal to discontinue the test for undue toxicity (chapter 3.7) in The International Pharmacopoeia | WHO Drug Information,2019,33,4 | 查看 |
Consultation Documents |
Tenofovir disoproxil fumarate (tenofoviri disoproxili fumaras) | WHO Drug Information,2019,33,4 | 查看 |
Consultation Documents |
Dolutegravir, Lamivudine and Tenofovir disoproxil fumarate (dolutegraviri, lamivudine et tenofoviri disoproxili fumarati compressi) | WHO Drug Information,2019,33,4 | 查看 |
Consultation Documents |
Dolutegravir tablets (dolutegravir compressi) | WHO Drug Information,2019,33,4 | 查看 |
Consultation Documents |
Dolutegravir sodium (dolutegravir natricum) | WHO Drug Information,2019,33,4 | 查看 |
Consultation Documents |
Draft monograph on sofosbuvir (sofosbuvirum) | WHO Drug Information,2019,33,4 | 查看 |
Consultation Documents |
Draft monograph on sofosbuvir tablets (sofosbuvir compressi) | WHO Drug Information,2019,33,4 | 查看 |
Consultation Documents |
Environmental aspects of manufacturing for the prevention of antimicrobial resistance | WHO Drug Information,2019,33,4 | 查看 |
International Nonproprietary N |
Recommended INN: List 82 | WHO Drug Information,2019,33,3 | 查看 |
Consultation Documents |
WHO/United Nations Population Fund (UNFPA) Condom Quality Assurance | WHO Drug Information,2019,33,3 | 查看 |
Consultation Documents |
WHO/United Nations Population Fund (UNFPA) Specifications for Plain Lubricants | WHO Drug Information,2019,33,3 | 查看 |
Consultation Documents |
WHO/UNITED NATIONS POPULATION FUND (UNFPA) GUIDANCE ON TESTING OF MALE LATEX CONDOMS | WHO Drug Information,2019,33,3 | 查看 |
Consultation Documents |
WHO/United Nations Population Fund (UNFPA) Recommendations for Condom Storage and Shipping Temperatures | WHO Drug Information,2019,33,3 | 查看 |